Elanco Wins USDA Approval for TruCan Ultra Lyme-L4 Vaccine
INDIANAPOLIS, June 15, 2026 Elanco Animal Health Incorporated has announced that the U.S. Department of Agriculture (USDA) has approved...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
INDIANAPOLIS, June 15, 2026 Elanco Animal Health Incorporated has announced that the U.S. Department of Agriculture (USDA) has approved...
REDWOOD CITY, Calif., May 18, 2026 Galvanize Therapeutics has announced that the U.S. Food and Drug Administration (FDA) granted...
OVERLAND PARK, Kan., May 19, 2026 Dechra has announced that the U.S. Food and Drug Administration (FDA) approved CosACTHen®...
RAHWAY, N.J., September 26, 2025 – Merck Animal Health, known as MSD Animal Health outside the U.S. and Canada...
